FeesSafety
Pluang+

Lexaria completes dosing in 5-week study comparing new oral semaglutide formulations to Wegovy tablets.

Market News
19 Nov 2026, 16:00 WIB
TheNewswire
View Source
Bullish
Lexaria completes dosing in 5-week study comparing new oral semaglutide formulations to Wegovy tablets.

Lexaria Bioscience has completed dosing in its 5-week Human Pilot Study #7, which compares two new oral DehydraTECH-semaglutide formulations to Novo's Wegovy tablets. The study aims to evaluate safety, tolerability, and pharmacokinetics of these new tablet and capsule forms containing SNAC, a first for Lexaria's multi-dose human trials. Results will be analyzed before any data is shared, with the goal of improving oral drug delivery and potentially enhancing commercial partnerships.

Lexaria's Human Study GLP-1-H26-7 dosing completion provides context for health sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 19, 2026 20:14 WIB: out of 150 priced US health stocks, 77 rose and 66 fell. Notable movers include ELAN at USD 27.25 (+2.06%), WGS at USD 53.00 (+2.00%) with 99% sell orders, and ALMS at USD 4.48 (+1.93%).

More News

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips launches Advanced Image Insights, a cloud AI tool to streamline radiology workflows and reporting.

Philips introduced Advanced Image Insights, a cloud-based solution that integrates advanced visualization and AI applications into radiology workflows. This platform connects image analysis with interactive reporting, helping radiologists manage comp...

Market News
Bullish
50 minutes ago
Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles boosts promotional menu capacity 8X and cuts shortages by 1,000 weekly with Armada's supply chain platform

Bojangles expanded its limited-time offers from 3 to 26 per year using Armada's PRO platform, improving supply chain visibility and coordination without adding staff. This led to a reduction of 1,000 weekly shortages and nearly perfect fill rates dur...

Market News
Bullish
50 minutes ago
Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney shows stronger stability and upside than Nvidia despite both being cheap stocks.

Disney and Nvidia both reported solid quarterly results and trade at about 16 times this year's earnings, making them historically cheap. Disney's stock is up 8% this year with a smooth CEO transition, while Nvidia's stock has slid 19% amid CEO scand...

Market News
Neutral
1 hour ago
Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

Financial sector ETF XLF underperforms despite rising rates; history suggests potential for gains ahead.

The State Street Financial Select Sector SPDR ETF (XLF), a major financial sector fund, has underperformed this year despite a rising interest rate environment that typically benefits financial stocks. With the Federal Reserve expected to raise rates...

Bullish
1 hour ago
Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy posts strong Q3 growth but stock drops amid AI spending uncertainty

Bloom Energy reported a robust third quarter with revenue up 138% year-over-year to $1.24 billion and operating income rising sharply to $225 million. Despite this growth and improved profitability, the stock has fallen over 40% from its highs due to...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App